NCT06833814View on ClinicalTrials.gov

DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

February 17, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Asthma Exacerbations

Interventions

DRUG

Prednisone

Either 150 mg over 3 days or 250 mg over 7 days or 350 mg over 10 days

All Listed Sponsors

lead

Andréanne Côté

OTHER